Stay updated on Risdiplam in SMA: Jewelfish Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA: Jewelfish Clinical Trial page.

Latest updates to the Risdiplam in SMA: Jewelfish Clinical Trial page
- CheckyesterdayChange DetectedThe record presents details of Hoffmann-La Roche’s completed Phase 2 risdiplam study for adults and children with spinal muscular atrophy, including eligibility criteria, study locations, and measured outcomes. It also provides results and related study documents.SummaryDifference61%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden message instead of the study record.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check36 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study page now renders a 403 Forbidden error instead of the expected study content. This prevents viewing the study details, documents, and locations on the page.SummaryDifference18%

- Check57 days agoChange DetectedThe page revision indicator was updated from v3.6.6 to v3.7.0, indicating an updated template or content version.SummaryDifference0.0%

Stay in the know with updates to Risdiplam in SMA: Jewelfish Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA: Jewelfish Clinical Trial page.